vs

Side-by-side financial comparison of Invesco (IVZ) and UPBOUND GROUP, INC. (UPBD). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.2B, roughly 1.4× UPBOUND GROUP, INC.). UPBOUND GROUP, INC. runs the higher net margin — 1.7% vs -58.9%, a 60.5% gap on every dollar of revenue. On growth, UPBOUND GROUP, INC. posted the faster year-over-year revenue change (10.9% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $24.0M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 4.5%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Upbound Group, Inc. is a leading US provider of flexible lease-to-own solutions for consumer goods. It offers furniture, consumer electronics, home appliances, and accessories, catering to customers seeking accessible payment alternatives to traditional retail financing.

IVZ vs UPBD — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.4× larger
IVZ
$1.7B
$1.2B
UPBD
Growing faster (revenue YoY)
UPBD
UPBD
+4.6% gap
UPBD
10.9%
6.2%
IVZ
Higher net margin
UPBD
UPBD
60.5% more per $
UPBD
1.7%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$408.2M more FCF
IVZ
$432.2M
$24.0M
UPBD
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
4.5%
UPBD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVZ
IVZ
UPBD
UPBD
Revenue
$1.7B
$1.2B
Net Profit
$-995.9M
$19.7M
Gross Margin
49.0%
Operating Margin
-86.2%
4.8%
Net Margin
-58.9%
1.7%
Revenue YoY
6.2%
10.9%
Net Profit YoY
-575.8%
-36.3%
EPS (diluted)
$-2.61
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
UPBD
UPBD
Q4 25
$1.7B
$1.2B
Q3 25
$1.6B
$1.2B
Q2 25
$1.5B
$1.2B
Q1 25
$1.5B
$1.2B
Q4 24
$1.6B
$1.1B
Q3 24
$1.5B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.5B
$1.1B
Net Profit
IVZ
IVZ
UPBD
UPBD
Q4 25
$-995.9M
$19.7M
Q3 25
$356.4M
$13.2M
Q2 25
$197.4M
$15.5M
Q1 25
$171.1M
$24.8M
Q4 24
$209.3M
$31.0M
Q3 24
$55.0M
$30.9M
Q2 24
$132.2M
$33.9M
Q1 24
$141.5M
$27.7M
Gross Margin
IVZ
IVZ
UPBD
UPBD
Q4 25
49.0%
Q3 25
48.3%
Q2 25
49.4%
Q1 25
46.8%
Q4 24
47.1%
Q3 24
47.8%
Q2 24
49.4%
Q1 24
48.3%
Operating Margin
IVZ
IVZ
UPBD
UPBD
Q4 25
-86.2%
4.8%
Q3 25
16.5%
4.5%
Q2 25
14.1%
4.4%
Q1 25
18.1%
5.3%
Q4 24
19.6%
7.3%
Q3 24
6.6%
6.6%
Q2 24
13.9%
7.5%
Q1 24
14.4%
5.6%
Net Margin
IVZ
IVZ
UPBD
UPBD
Q4 25
-58.9%
1.7%
Q3 25
21.7%
1.1%
Q2 25
13.0%
1.3%
Q1 25
11.2%
2.1%
Q4 24
13.1%
2.9%
Q3 24
3.6%
2.9%
Q2 24
8.9%
3.2%
Q1 24
9.6%
2.5%
EPS (diluted)
IVZ
IVZ
UPBD
UPBD
Q4 25
$-2.61
$0.35
Q3 25
$0.66
$0.22
Q2 25
$-0.03
$0.26
Q1 25
$0.38
$0.42
Q4 24
$0.46
$0.55
Q3 24
$0.12
$0.55
Q2 24
$0.29
$0.61
Q1 24
$0.31
$0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
UPBD
UPBD
Cash + ST InvestmentsLiquidity on hand
$1.0B
$120.5M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
$695.7M
Total Assets
$27.1B
$3.3B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
UPBD
UPBD
Q4 25
$1.0B
$120.5M
Q3 25
$973.1M
$107.0M
Q2 25
$922.7M
$106.8M
Q1 25
$821.7M
$107.3M
Q4 24
$986.5M
$60.9M
Q3 24
$1.0B
$85.1M
Q2 24
$878.5M
$82.5M
Q1 24
$895.7M
$84.8M
Total Debt
IVZ
IVZ
UPBD
UPBD
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
IVZ
IVZ
UPBD
UPBD
Q4 25
$12.2B
$695.7M
Q3 25
$14.0B
$687.3M
Q2 25
$13.9B
$685.5M
Q1 25
$14.7B
$679.2M
Q4 24
$14.6B
$629.0M
Q3 24
$14.8B
$611.8M
Q2 24
$14.6B
$596.3M
Q1 24
$14.6B
$578.3M
Total Assets
IVZ
IVZ
UPBD
UPBD
Q4 25
$27.1B
$3.3B
Q3 25
$28.4B
$3.2B
Q2 25
$28.5B
$3.1B
Q1 25
$28.1B
$3.0B
Q4 24
$27.0B
$2.6B
Q3 24
$27.5B
$2.6B
Q2 24
$27.2B
$2.6B
Q1 24
$28.1B
$2.6B
Debt / Equity
IVZ
IVZ
UPBD
UPBD
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
UPBD
UPBD
Operating Cash FlowLast quarter
$455.8M
$41.6M
Free Cash FlowOCF − Capex
$432.2M
$24.0M
FCF MarginFCF / Revenue
25.5%
2.0%
Capex IntensityCapex / Revenue
1.4%
1.5%
Cash ConversionOCF / Net Profit
2.11×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$238.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
UPBD
UPBD
Q4 25
$455.8M
$41.6M
Q3 25
$606.2M
$118.4M
Q2 25
$547.9M
$7.8M
Q1 25
$-84.6M
$137.7M
Q4 24
$316.9M
$-61.9M
Q3 24
$438.4M
$106.2M
Q2 24
$489.1M
$15.0M
Q1 24
$-54.4M
$45.4M
Free Cash Flow
IVZ
IVZ
UPBD
UPBD
Q4 25
$432.2M
$24.0M
Q3 25
$586.4M
$97.9M
Q2 25
$530.4M
$-10.4M
Q1 25
$-108.0M
$127.2M
Q4 24
$309.9M
$-74.0M
Q3 24
$410.0M
$88.3M
Q2 24
$462.4M
$613.0K
Q1 24
$-75.4M
$33.6M
FCF Margin
IVZ
IVZ
UPBD
UPBD
Q4 25
25.5%
2.0%
Q3 25
35.7%
8.4%
Q2 25
35.0%
-0.9%
Q1 25
-7.1%
10.8%
Q4 24
19.5%
-6.9%
Q3 24
27.1%
8.3%
Q2 24
31.2%
0.1%
Q1 24
-5.1%
3.1%
Capex Intensity
IVZ
IVZ
UPBD
UPBD
Q4 25
1.4%
1.5%
Q3 25
1.2%
1.8%
Q2 25
1.2%
1.6%
Q1 25
1.5%
0.9%
Q4 24
0.4%
1.1%
Q3 24
1.9%
1.7%
Q2 24
1.8%
1.3%
Q1 24
1.4%
1.1%
Cash Conversion
IVZ
IVZ
UPBD
UPBD
Q4 25
2.11×
Q3 25
1.70×
8.96×
Q2 25
2.78×
0.50×
Q1 25
-0.49×
5.56×
Q4 24
1.51×
-2.00×
Q3 24
7.97×
3.44×
Q2 24
3.70×
0.44×
Q1 24
-0.38×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

UPBD
UPBD

Segment breakdown not available.

Related Comparisons